Brussels G7 Summit Declaration

The Brussels G7 Summit Declaration
European Commission – MEMO/14/402 05/06/2014
…21. We remain committed to the Muskoka Initiative on maternal, newborn and child health, and welcome the call made at the Saving Every Woman, Every Child Summit in Toronto to accelerate progress on this global priority. In addition we are committed to ensuring sexual and reproductive health and reproductive rights, and ending child, early and forced marriage and female genital mutilation and other harmful practices. The health and well-being of women and children are improved through ensuring universal access to affordable, quality, essential health services, strengthening health, education and child protection systems and improving nutrition and access to immunisation. We recognise the impact of the GAVI Alliance (Global Alliance for Vaccines and Immunisation) and welcome its efforts to expand access to vaccines to an additional 300 million children during 2016-2020. We welcome Germany’s offer to host the second replenishment in early 2015, reaffirm our commitment, and call on other public and private donors to contribute to the replenishment of the GAVI Alliance. We reaffirm our commitment to an AIDS free generation and to the Global Fund to fight AIDS, Tuberculosis and Malaria to reduce the burden of these three major infectious diseases on eligible countries and regions.

22. To address the threat posed by infectious diseases, we support the Global Health Security Agenda and commit to working with partner countries to strengthen compliance with the World Health Organisation’s (WHO) International Health Regulations and enhance health security around the world. We commit to working across sectors to prevent, detect and respond to infectious diseases, whether naturally occurring, accidental, or the result of a deliberate act by a state or non-state actor. That includes building global capacity so that we are better prepared for threats such as the recent Ebola outbreak in West Africa and working together, in close cooperation with WHO, to develop a Global Action Plan on antimicrobial resistance….

G7 Summit in Brussels, 4 – 5 June 2014: Background note and facts about the EU’s role and actions
European Commission – MEMO/14/392 03/06/2014
4. Development
…On 20 May, the EU announced that it will provide €25 million per year in the period 2014-2020 to fund vaccines and immunisation programmes worldwide through the GAVI alliance – more than double than previously committed. Since 2003, the European Commission has committed over €83 million to the GAVI Alliance, coming in part from the Development Co-operation Instrument (DCI) and in part from the European Development Fund (EDF). Thanks to donors like the EU, close to half a billion children have been immunised since 2000, resulting in 6 million lives saved….
WHO: Global Alert and Response (GAR) – Disease Outbreak News [to 7 June 2014]
:: Ebola virus disease, West Africa – update 4 June 2014
:: Middle East respiratory syndrome coronavirus (MERS-CoV) – update 4 June 2014

WHO concludes a MERS-CoV risk assessment mission in the United Arab Emirates
6 June 2014
A team from the WHO and technical partners from the Global Outbreak Alert and Response Network (GOARN) has concluded a 5 day mission in United Arab Emirates (UAE).
The team assessed the risk posed by the Middle East respiratory syndrome coronavirus, or MERS-CoV in the country. The team consisted of 6 experts in coordination, epidemiology, infection prevention and control, food safety and the human-animal interface, and risk communication.
Health authorities in the UAE had invited WHO to review the current situation after an upsurge in MERS-CoV infections in April. Upon arrival, the WHO team met with H.E Mr Abdul Rahman bin Mohammed Al Owais, the Minister of Health, in Dubai to discuss the mission.
Investigation and evaluation
During the mission, the team had extensive meetings with experts from Health Authority Abu Dhabi, Dubai Health Authority and the Abu Dhabi Food Control Authority. The team visited the hospital to which two-thirds of the country’s cases can be traced, in order to review the epidemiological investigation and assess the infection prevention and control measures that have been applied. The WHO team evaluated the work done on investigating possible exposure routes, transmission patterns, and the clinical situation.
“We are impressed by the amount of data and information generated during the investigation of MERS cases by UAE to help better understand MERS- CoV. This knowledge is of utmost importance to the rest of the world to better discover the source of the virus and the routes of transmissions from animals to humans, “said Peter Ben Embarek, WHO team leader.
“The UAE health authorities have been following up diligently on the MERS-CoV cases, including repeated laboratory testing to check when cases have been cleared of the virus. This data will make an important contribution to the risk assessment and to guide the health response internationally,” Ben Embarek concluded.
Need to share experience and knowledge
The preliminary result of the mission indicates that the cases in UAE do not show evidence of sustained human to human infection. The recent upsurge of cases in Abu Dhabi appears to have been caused by a combination of factors, including a breach in infection prevention and control measures in health care settings, active surveillance and increase in community acquired cases…